Stay updated on VIS410 Influenza Challenge Study Clinical Trial
Sign up to get notified when there's something new on the VIS410 Influenza Challenge Study Clinical Trial page.

Latest updates to the VIS410 Influenza Challenge Study Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated to v3.3.2 in the footer, replacing v3.3.1. This is a minor version update and does not alter the study content or page functionality.SummaryDifference0.1%

- Check21 days agoChange DetectedPublications note updated to indicate automatic PubMed filling and potential non-study relevance, and Revision: v3.3.1 was added; the deletions refer to the previous PubMed note and Revision: v3.2.0.SummaryDifference0.1%

- Check29 days agoChange Detected- Removed the government funding lapse notice from the page, and no core study details appear to be altered. All primary study information (title, NCT identifier, eligibility criteria, locations, and outcome measures) remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe update appears to be a UI/layout change with no modifications to core study details such as inclusion criteria, primary outcomes, locations, or study status; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference4%

- Check79 days agoChange DetectedAdded: Revision: v3.1.0. Removed: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and an earlier Revision: v3.0.2, indicating a shift away from detailed drug-safety topics and toward a new version label.SummaryDifference0.5%

Stay in the know with updates to VIS410 Influenza Challenge Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS410 Influenza Challenge Study Clinical Trial page.